1. Home
  2. CBU vs ADPT Comparison

CBU vs ADPT Comparison

Compare CBU & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBU

Community Bank System Inc.

HOLD

Current Price

$61.91

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$17.53

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBU
ADPT
Founded
1866
2009
Country
United States
United States
Employees
N/A
624
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.7B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CBU
ADPT
Price
$61.91
$17.53
Analyst Decision
Hold
Strong Buy
Analyst Count
4
9
Target Price
$66.67
$17.78
AVG Volume (30 Days)
248.3K
3.0M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
3.02%
N/A
EPS Growth
15.41
63.89
EPS
1.08
N/A
Revenue
$818,007,000.00
$276,976,000.00
Revenue This Year
$13.46
$3.98
Revenue Next Year
$7.75
$22.72
P/E Ratio
$57.35
N/A
Revenue Growth
9.61
54.77
52 Week Low
$51.12
$9.96
52 Week High
$67.50
$20.76

Technical Indicators

Market Signals
Indicator
CBU
ADPT
Relative Strength Index (RSI) 43.74 58.90
Support Level $60.93 $14.87
Resistance Level $64.83 $17.72
Average True Range (ATR) 1.61 1.36
MACD -0.29 0.01
Stochastic Oscillator 18.92 56.11

Price Performance

Historical Comparison
CBU
ADPT

About CBU Community Bank System Inc.

Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional, and governmental customers. The Company also offers comprehensive financial planning, trust administration, and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services, and Wealth Management Services. The group generates the majority of its revenue from the Banking and Corporate segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: